J&J Medical Connect
RYBREVANT®

(amivantamab-vmjw)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

Can RYBREVANT Cause Eye Problems?

Last Updated: 12/19/2024

summary

Here is a passage from the RYBREVANT PATIENT INFORMATION which may be helpful to address your question:

Can RYBREVANT cause eye problems?

  • RYBREVANT may cause serious side effects, including eye problems. RYBREVANT may cause eye problems. Tell your healthcare provider right away if you get symptoms of eye problems which may include1:
    • eye pain
    • inflammation of eye lids
    • dry eyes
    • eye redness
    • blurred vision
    • changes in vision
    • itchy eyes
    • excessive tearing
    • sensitivity to light

Your healthcare provider may send you to see an eye specialist (ophthalmologist) if you get new or worsening eye problems during treatment with RYBREVANT. You should not use contact lenses until your eye symptoms are checked by a healthcare provider.1

Your healthcare provider may temporarily stop, decrease your dose, or completely stop your treatment with RYBREVANT if you have serious side effects.1

These are not all of the possible side effects of RYBREVANT.1

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.1

ADDITIONAL INFORMATION

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for RYBREVANT.1

 

References

1 RYBREVANT (amivantamab-vmjw) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/RYBREVANT-pi.pdf